Advisors Asset Management, Inc. Sangamo Therapeutics, Inc Transaction History

Advisors Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $59,948 - $105,058	-11,871 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$8.03 - $11.7 $49,151 - $71,615	-6,121 Reduced 34.02%	11,871 $99,000
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $3,755 - $5,071	-415 Reduced 2.25%	17,992 $163,000
Q2 2019 Aug 14, 2019	SELL	$8.75 - $13.03 $3,998 - $5,954	-457 Reduced 2.42%	18,407 $198,000
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $4,315 - $7,160	-559 Reduced 2.88%	18,864 $180,000
Q4 2018 Jan 31, 2019	SELL	$9.51 - $16.6 $10,879 - $18,990	-1,144 Reduced 5.56%	19,423 $223,000
Q3 2018 Nov 15, 2018	SELL	$13.05 - $19.05 $8,091 - $11,811	-620 Reduced 2.93%	20,567 $349,000
Q2 2018 Aug 22, 2018	BUY	$13.9 - $19.8 $127,421 - $181,506	9,167 Added 76.26%	21,187 $301,000
Q2 2018 Aug 15, 2018	BUY	$13.9 - $19.8 $94,422 - $134,501	6,793 Added 129.96%	12,020 $301,000
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $71,325 - $112,540	4,271 Added 446.76%	5,227 $125,000
Q4 2017 Feb 13, 2018	BUY	$11.6 - $17.35 $11,089 - $16,586	956	956 $16,000

141

60.4M

1.46M

1.84M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $153M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.